Camp4 Therapeutics Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q4 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Camp4 Therapeutics Corp
Access all reports
Camp4 Therapeutics Corp is a biotechnology company focused on developing RNA-based therapeutics. The company leverages a proprietary platform to identify and regulate gene expression through RNA technologies, aiming to address a range of diseases driven by dysregulated gene activity. Camp4 Therapeutics' research and development activities span multiple therapeutic areas, applying its platform to discover potential treatments targeting specific genetic mechanisms. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Camp4 Therapeutics Corp
43rd Annual J.P. Morgan Healthcare Conference
Camp4 Therapeutics Corp
43rd Annual J.P. Morgan Healthcare Conference
Camp4 Therapeutics Corp
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
CAMP
Country
🇺🇸 United States